{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:24:19Z","timestamp":1773296659963,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Major National Basic Research Program of P. R. China","award":["2011CB503904"],"award-info":[{"award-number":["2011CB503904"]}]},{"name":"the Beijing Natural Science Foundation","award":["7142060"],"award-info":[{"award-number":["7142060"]}]},{"DOI":"10.13039\/501100001809","name":"the Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["81270369, 81070244"],"award-info":[{"award-number":["81270369, 81070244"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the foundation of Beijing Key Laboratory of Metabolic Disturbance Related Cardiovascular Disease"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0293-5","type":"journal-article","created":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T20:46:02Z","timestamp":1469479562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study"],"prefix":"10.1186","volume":"15","author":[{"given":"Ning","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"issue":"2","key":"293_CR1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000351249","volume":"2","author":"KA Iwen","year":"2013","unstructured":"Iwen KA, Schr\u00f6der E, Brabant G. Thyroid hormones and the metabolic syndrome. Eur Thyroid J. 2013;2(2):83\u201392.","journal-title":"Eur Thyroid J"},{"issue":"3\u20134","key":"293_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vph.2009.09.004","volume":"52","author":"T Ichiki","year":"2010","unstructured":"Ichiki T. Thyroid hormone and atherosclerosis. Vascul Pharmacol. 2010;52(3\u20134):151\u20136.","journal-title":"Vascul Pharmacol"},{"issue":"6","key":"293_CR3","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1210\/jc.2003-030398","volume":"88","author":"AR Cappola","year":"2003","unstructured":"Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88(6):2438\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"293_CR4","first-page":"1211","volume":"27","author":"C Neves","year":"2008","unstructured":"Neves C, Alves M, Medina JL, Delgado JL. Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol. 2008;27(10):1211\u201336.","journal-title":"Rev Port Cardiol"},{"issue":"2","key":"293_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/jc.2006-1605","volume":"92","author":"M Ito","year":"2007","unstructured":"Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, et al. Effect of levothyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab. 2007;92(2):608\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"293_CR6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11883-003-0010-5","volume":"5","author":"PP Toth","year":"2003","unstructured":"Toth PP. Reverse cholesterol transport: high-density lipoprotein's magnificent mile. Curr Atheroscler Rep. 2003;5(5):386\u201393.","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"293_CR7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","volume":"62","author":"T Gordon","year":"1977","unstructured":"Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62(5):707\u201314.","journal-title":"Am J Med"},{"key":"293_CR8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/1476-511X-12-176","volume":"12","author":"J Wang","year":"2013","unstructured":"Wang J, Wang LJ, Zhong Y, Gu P, Shao JQ, Jiang SS, et al. CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population. Lipids Health Dis. 2013;12:176.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"293_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2010.12.003","volume":"130","author":"DO Osei-Hwedieh","year":"2011","unstructured":"Osei-Hwedieh DO, Amar M, Sviridov D, Remaley AT. Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents. Pharmacol Ther. 2011;130(1):83\u201391.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"293_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011;8(4):222\u201332.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"293_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0021-9150(00)00537-2","volume":"155","author":"MS Morris","year":"2001","unstructured":"Morris MS, Bostom AG, Jacques PF, Selhub J, Rosenberg IH. Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination Survey. Atherosclerosis. 2001;155(1):195\u2013200.","journal-title":"Atherosclerosis"},{"issue":"2","key":"293_CR12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/2193-1801-2-423","volume":"30","author":"SA Bamashmoos","year":"2013","unstructured":"Bamashmoos SA, Al-Nuzaily MA, Al-Meeri AM, Ali FH. Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patiens. Springerplus. 2013;30(2):423.","journal-title":"Springerplus"},{"key":"293_CR13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2261-6-38","volume":"6","author":"S Sadeghian","year":"2006","unstructured":"Sadeghian S, Fallahi F, Salarifar M, Davoodi G, Mahmoodian M, Fallah N, et al. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord. 2006;6:38.","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"293_CR14","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1182\/blood-2002-08-2606","volume":"101","author":"H Wang","year":"2003","unstructured":"Wang H, Jiang X, Yang F, Gaubatz JW, Ma L, Magera MJ, et al. Hyperhomocysteinemia accelerates atherosclerosis in cystathionine beta-synthase and apolipoprotein E double knock-out mice with and without dietary perturbation. Blood. 2003;101(10):3901\u20137.","journal-title":"Blood"},{"issue":"5","key":"293_CR15","doi-asserted-by":"crossref","first-page":"e0125922","DOI":"10.1371\/journal.pone.0125922","volume":"10","author":"N Yang","year":"2015","unstructured":"Yang N, Yao Z, Miao L, Liu J, Gao X, Fan H, et al. Novel Clinical Evidence of an Association between Homocysteine and Insulin Resistance in Patients with Hypothyroidism or Subclinical Hypothyroidism. PLoS One. 2015;10(5):e0125922.","journal-title":"PLoS One"},{"key":"293_CR16","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng J, et al. Hyperhomocysteinemia Promotes Insulin Resistance by Inducing Endoplasmic Reticulum Stress in Adipose Tissue. J. Biol. Chem. 2013;288:9583\u201392.","DOI":"10.1074\/jbc.M112.431627"},{"key":"293_CR17","doi-asserted-by":"crossref","unstructured":"Liu J, Xu Y, Zhang H, Gao X, Fan H, Wang G. Coronary flow velocity reserve is impaired in hypertensive patients with hyperhomocysteinemia. J Hum Hypertens. 2014;28(12):743\u20137.","DOI":"10.1038\/jhh.2014.22"},{"issue":"2","key":"293_CR18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2010.11.031","volume":"214","author":"RM Gu\u00e9ant-Rodriguez","year":"2011","unstructured":"Gu\u00e9ant-Rodriguez RM, Spada R, Moreno-Garcia M, Anello G, Bosco P, Lagrost L, et al. Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population. Atherosclerosis. 2011;214(2):480\u20135.","journal-title":"Atherosclerosis"},{"key":"293_CR19","doi-asserted-by":"crossref","unstructured":"Liao D, Yang X, Wang H. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med. 2007;45(12):1652\u20139.","DOI":"10.1515\/CCLM.2007.358"},{"key":"293_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1476-511X-10-137","volume":"10","author":"Y Xiao","year":"2011","unstructured":"Xiao Y, Zhang Y, Lv X, Su D, Li D, Xia M, et al. Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects. Lipids Health Dis. 2011;10:137.","journal-title":"Lipids Health Dis"},{"issue":"Suppl 9","key":"293_CR21","first-page":"155","volume":"59","author":"H Jakubowski","year":"2008","unstructured":"Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol. 2008;59 Suppl 9:155\u201367.","journal-title":"J Physiol Pharmacol"},{"issue":"6","key":"293_CR22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/hsz-2013-0262","volume":"395","author":"A Miyazaki","year":"2014","unstructured":"Miyazaki A, Sagae N, Usami Y, Sato M, Kameda T, Yoshimoto A, et al. N-homocysteinylation of apolipoprotein A-I impairs the protein's antioxidant ability but not its cholesterol efflux capacity. Biol Chem. 2014;395(6):641\u20138.","journal-title":"Biol Chem"},{"issue":"6","key":"293_CR23","doi-asserted-by":"crossref","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988\u20131028.","journal-title":"Endocr Pract"},{"issue":"2","key":"293_CR24","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","volume":"291","author":"MI Surks","year":"2004","unstructured":"Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291(2):228\u201338.","journal-title":"JAMA"},{"issue":"6","key":"293_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.amjmed.2009.12.023","volume":"123","author":"DD Jones","year":"2010","unstructured":"Jones DD, May KE, Geraci SA. Subclinical thyroid disease. Am J Med. 2010;123(6):502\u20134.","journal-title":"Am J Med"},{"issue":"6","key":"293_CR26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/CBI20110235","volume":"36","author":"D Wang","year":"2012","unstructured":"Wang D, Wang H, Luo P, Hwang A, Sun D, Wang Y, et al. Effects of ghrelin on homocysteine-induced dysfunction and inflammatory response in rat cardiac microvascular endothelial cells. Cell Biol Int. 2012;36(6):511\u20137.","journal-title":"Cell Biol Int"},{"key":"293_CR27","doi-asserted-by":"crossref","unstructured":"Edirimanne VE, Woo CW, Siow YL, Pierce GN, Xie JY, O K. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can J Physiol Pharmacol. 2007;85(12):1236\u201347.","DOI":"10.1139\/Y07-112"},{"issue":"12","key":"293_CR28","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.3748\/wjg.v10.i12.1699","volume":"10","author":"C Ji","year":"2004","unstructured":"Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastroenterol. 2004;10(12):1699\u2013708.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"293_CR29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/jcp.22415","volume":"226","author":"JK Chiang","year":"2011","unstructured":"Chiang JK, Sung ML, Yu HR, Chang HI, Kuo HC, Tsai TC, et al. Homocysteine induces smooth muscle cell proliferation through differential regulation of cyclins A and D1 expression. J Cell Physiol. 2011;226(4):1017\u201326.","journal-title":"J Cell Physiol"},{"issue":"6","key":"293_CR30","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"D Liao","year":"2006","unstructured":"Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, et al. Hyperhomocysteinemia decreases circulating highdensity lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006;99(6):598\u2013606.","journal-title":"Circ Res"},{"issue":"4","key":"293_CR31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","volume":"98","author":"LG Mikael","year":"2006","unstructured":"Mikael LG, Genest Jr J, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res. 2006;98(4):564\u201371.","journal-title":"Circ Res"},{"issue":"4","key":"293_CR32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","volume":"12","author":"LH Duntas","year":"2002","unstructured":"Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287\u201393.","journal-title":"Thyroid"},{"issue":"2","key":"293_CR33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2004.10.033","volume":"179","author":"G Wang","year":"2005","unstructured":"Wang G, Dai J, Mao J, Zeng X, Yang X, Wang X. Folic acid reverses hyper-responsiveness of LPS-induced chemokine secretion from monocytes in patients with hyperhomocysteinemia. Atherosclerosis. 2005;179(2):395\u2013402.","journal-title":"Atherosclerosis"},{"key":"293_CR34","doi-asserted-by":"crossref","first-page":"109797","DOI":"10.1155\/2012\/109797","volume":"2012","author":"M Gunduz","year":"2012","unstructured":"Gunduz M, Gunduz E, Kircelli F, Okur N, Ozkaya M. Role of surrogate markers of atherosclerosis in clinical and subclinical thyroidism. Int J Endocrinol. 2012;2012:109797.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"293_CR35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2265.2001.01170.x","volume":"54","author":"MJ Diekman","year":"2001","unstructured":"Diekman MJ, van der Put NM, Blom HJ, Tijssen JG, Wiersinga WM. Determinants of changes in plasma homocysteine in hyperthyroidism and hypothyroidism. Clin Endocrinol (Oxf). 2001;54(2):197\u2013204.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0293-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:08:05Z","timestamp":1498316885000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0293-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0293-5","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]},"article-number":"123"}}